All employees at the Irish manufacturing arm of pharmaceuticals giant Roche in Clarecastle, Co Clare, will be made redundant by June 2020, according to newly filed company accounts for Roche Ireland.
The documents show that the firm recorded pre-tax losses of €1.7m last year as revenues decreased by 11pc to €60.29m.
Some 132 workers were employed at the plant at the end of December. The directors stated that decommissioning works will commence next year and continue to 2023.
The Swiss company announced in 2016 it would close the plant at Clarecastle after failing to secure a buyer for the site.
The facility is currently in the process of a phased shutdown. The directors stated this will process will finish by mid-March 2020.
The accounts disclosed that the firm has set aside €24m for employees not yet departed but who have an expectation of employment termination by 2020.
The directors state that “this will be utilised by that date”.
If the 132 employed at the end of last year stay on until next year, the average redundancy payment will be around €180,000 each.
The accounts also confirm that a decommissioning provision of €9m for the plant was recorded by the end of last year.
A note attached to the accounts states that the estimate could change substantially as new facts emerge.
Staff costs at the company increased from €16.8m to €17m. A breakdown of the numbers employed shows that 122 were engaged in production, six in administration and four in management.
Directors’ pay totalled €327,000.
Source: Read Full Article